Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Tuesday evening:

Skechers USA (SKX - Get Report) : "This one has been crushed and I want you to buy Skechers and not sell it."

Gilead Sciences (GILD - Get Report) : "I still like Gilead, Celgene (CELG - Get Report) , Regeneron Pharmaceuticals (REGN - Get Report) and Biogen Idec (BIIB - Get Report) ."

Juno Therapeutics (JUNO) : "I don't like Juno as much as Halozyme Therapeutics (HALO - Get Report) or Radius Health (RDUS - Get Report) if you want to go speculative."

DuPont (DD - Get Report) : "I think that stock is already up too much. Let it come in."

Procter & Gamble (PG - Get Report) : "This one seems to be done going down."

Priceline Group (PCLN) : "This one is overdone to the downside, but buy it with deep-in-the-money call options."

Sierra Wireless (SWIR - Get Report) : "I'd rather go with IDT Corporation (IDT - Get Report) ."

Kohlberg Kravis Roberts (KKR - Get Report) : "I like KKR and Blackstone Group (BX - Get Report) ."

Pfizer (PFE - Get Report) : "I like Pfizer, but don't forget that Eli Lilly (LLY - Get Report) and Bristol-Myers Squibb (BMY - Get Report) are better."

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.


At the time of publication, Cramer's Action Alerts PLUS had a position in BIIB.